About Steven Elms
Steven Elms is a director and 10% owner at Adma Biologics.
Form D filings name Steven Elms as a director at Treeline Biosciences.
Steven Elms reports to the SEC as a director or major shareholder of 21 public companies, including Marker Therapeutics (MRKR), Elevation Oncology (ELEV) and Zosano Pharma (ZSAN).
Steven Elms first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name Steven Elms in the role, so the role may have started earlier or lasted longer.
AI
Adma Biologics, Inc.
Director and 10% owner
2012 – 2026 · Public company (ADMA)
MI
Marker Therapeutics, Inc.
Director
2019 – 2025 · Public company (MRKR)
EI
Elevation Oncology, Inc.
Director and 10% owner
2021 – 2025 · Public company (ELEV)
ZC
Zosano Pharma Corp
Director and 10% owner
2018 – 2021 · Public company (ZSAN)
VI
Viracta Therapeutics, Inc.
10% owner
2019 · Public company (VIRX)
LI
Loxo Oncology, Inc.
Director and 10% owner
2014 – 2019 · Public company (LOXO)
SI
Syros Pharmaceuticals, Inc.
10% owner
2016 · Public company (SYRS)
AI
Agile Therapeutics Inc.
Director and 10% owner
2014 – 2016 · Public company (AGRX)
PI
Pernix Therapeutics Holdings, Inc.
Director
2012 – 2016 · Public company (PTX)
VI
ViewRay, Inc.
10% owner
2016 · Public company (VRAY)
AI
Asensus Surgical, Inc.
10% owner
2013 – 2016 · Public company (ASXC)
TI
T2 Biosystems, Inc.
Director and 10% owner
2014 – 2015 · Public company (TTOO)
EI
Esperion Therapeutics, Inc.
10% owner
2013 – 2015 · Public company (ESPR)
CI
Cidara Therapeutics, Inc.
Director
2015 · Public company (CDTX)
AI
Aravive, Inc.
10% owner
2014 – 2015 · Public company (ARAV)
AC
Ambit Biosciences Corp.
Director
2013 – 2014 · Public company (AMBI)
DI
Durata Therapeutics, Inc.
10% owner
2012 – 2014 · Public company (DRTX)
ZI
Zeltiq Aesthetics Inc
10% owner
2011 – 2014 · Public company (ZLTQ)
MN
Melinta Therapeutics, Inc. /new/
10% owner
2012 · Public company (MLNT)
MI
MAP Pharmaceuticals, Inc.
Director
2007 – 2010 · Public company (MAPP)
II
Interpharm Holdings Inc.
10% owner
2007 – 2008 · Public company (IPA)
Key Colleagues at Startups
The people Steven Elms works with at each company, as listed on that company's latest Form D.
Treeline Biosciences, Inc. · Form D, Sep 4, 2025
KB
Kristina Burow
Director
DB
David Bonita
Director
JB
Joshua Bilenker
Executive officer, director and promoter
JE
Jeffrey Engelman
Executive officer, director and promoter
AK
Aftab Kherani
Director
AS
Ali Satvat
Director
Avi Naider
Director
DS
David Schenkein
Director